LataMed AI Corp. (OTC: LMED), a healthcare technology company focused on Latin America, announced that it will participate in the Artificial Intelligence & Health Markets 2026 conference, scheduled for August 13-14, 2026, at Universidad Santa Maria in Caracas, Venezuela. The event aims to bring together students, faculty, and professionals from systems engineering and healthcare fields to explore practical applications of AI and automation.
Representing LataMed AI will be Dr. Kevin Rodan Levy, Chief Executive Officer, and Carlos Pena, Chief Financial Officer. Their presentation is expected to address the evolving role of AI in healthcare, systems engineering, digital infrastructure, and professional decision-making. The company plans to discuss how AI-supported tools can assist healthcare professionals with data evaluation, clinical workflows, and operational efficiency, while also examining how automation can enhance the reliability and organization of complex technology systems.
A key focus of the presentation will be the importance of qualified professional oversight in AI implementation. LataMed AI emphasizes that its technologies are designed to augment human capabilities and support informed decisions, not replace the judgment of healthcare professionals, engineers, or laboratory personnel. The conference topics will also cover responsible data use, privacy, cybersecurity, operational risk management, and practical considerations for deploying AI in healthcare settings.
LataMed AI also intends to discuss its ongoing development of a healthcare technology ecosystem, including CardioAI, PulmoAI, and NeuroAI—AI-supported platforms for cardiovascular, pulmonary, and neurological health evaluation. These platforms are still in development and subject to testing, regulatory approvals, and commercial rollout.
“Artificial Intelligence & Health Markets 2026 provides an important opportunity to engage directly with students, educators, and future professionals who will help shape the responsible use of artificial intelligence in healthcare and systems engineering,” said Dr. Kevin Rodan Levy. “Our objective is to share practical perspectives on how intelligent technologies can support professional decision-making, improve digital workflows, and contribute to the continued development of healthcare infrastructure in Latin America.”
Management believes that university engagement can raise awareness of emerging healthcare technologies, promote responsible AI discussions, and build relationships with future professionals. The event also offers LataMed AI insights into the perspectives of students, educators, and researchers as it develops solutions for the region.
LataMed AI’s participation aligns with its broader strategy of supporting education and responsible digital healthcare adoption in Latin America. The company will continue exploring opportunities to join academic, healthcare, and technology forums that match its objectives. However, participation in the conference does not imply endorsement by Universidad Santa Maria, nor does it guarantee future collaborations, regulatory approvals, revenue, or financial benefits.
For more information, visit latamed.ai or review filings with the U.S. Securities and Exchange Commission at www.sec.gov.
